Advances in antiretroviral therapy have transformed HIV into a well‑managed chronic condition, yet significant regulatory and operational barriers persist for pilots living with HIV, including inconsistent certification practices and restrictions that may prevent entry into or continuation of an aviation career. IFALPA highlights the misalignment between current aeromedical guidance and contemporary medical evidence. Outdated policies on flying with HIV can create unnecessary limitations, operational complexity, and stigma, while potentially discouraging transparent health disclosure. Aligning regulatory frameworks with current science and human rights principles will enhance both equity and flight safety by enabling qualified pilots living with HIV to operate without unnecessary restriction or stigma.
Related Publications

Smoking and Aircrew
Cigarette smoking remains a major preventable health risk, contributing to severe diseases such as lung cancer, heart disease, and stroke.

COVID-19 Guidance For Crews
At all times, crews should follow the advice of their health authorities and operators. This updated Safety Bulletin provides

Medication and Flying
Even a minor illness in a pilot can cause a major problem while flying. In addition, accidents have occurred because

Aircrews and Ionizing Radiation
Flying exposes crew members to ionizing and non-ionizing radiation. Ionizing radiation has the potential to result in cancer, cardiovascular disease,

Sleep Apnea Information for Pilots
The prevalence of sleep apnea in adults is estimated to be 7%. In contrast, the US Federal Aviation Administration (FAA)

Malaria Information for Pilots
Malaria is a common and life-threatening disease found in many tropical and subtropical countries. Malaria is transmitted to humans by